217 related articles for article (PubMed ID: 24785509)
21. Genome-wide association study to identify single nucleotide polymorphisms (SNPs) associated with the development of erectile dysfunction in African-American men after radiotherapy for prostate cancer.
Kerns SL; Ostrer H; Stock R; Li W; Moore J; Pearlman A; Campbell C; Shao Y; Stone N; Kusnetz L; Rosenstein BS
Int J Radiat Oncol Biol Phys; 2010 Dec; 78(5):1292-300. PubMed ID: 20932654
[TBL] [Abstract][Full Text] [Related]
22. A 2-stage genome-wide association study to identify single nucleotide polymorphisms associated with development of erectile dysfunction following radiation therapy for prostate cancer.
Kerns SL; Stock R; Stone N; Buckstein M; Shao Y; Campbell C; Rath L; De Ruysscher D; Lammering G; Hixson R; Cesaretti J; Terk M; Ostrer H; Rosenstein BS
Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):e21-8. PubMed ID: 23021708
[TBL] [Abstract][Full Text] [Related]
23. Integrated models for the prediction of late genitourinary complaints after high-dose intensity modulated radiotherapy for prostate cancer: making informed decisions.
De Langhe S; De Meerleer G; De Ruyck K; Ost P; Fonteyne V; De Neve W; Thierens H
Radiother Oncol; 2014 Jul; 112(1):95-9. PubMed ID: 24951017
[TBL] [Abstract][Full Text] [Related]
24. Polymorphic Variants in Oxidative Stress Genes and Acute Toxicity in Breast Cancer Patients Receiving Radiotherapy.
Córdoba EE; Abba MC; Lacunza E; Fernánde E; Güerci AM
Cancer Res Treat; 2016 Jul; 48(3):948-54. PubMed ID: 26790968
[TBL] [Abstract][Full Text] [Related]
25. Association between SNPs in defined functional pathways and risk of early or late toxicity as well as individual radiosensitivity.
Reuther S; Szymczak S; Raabe A; Borgmann K; Ziegler A; Petersen C; Dikomey E; Hoeller U
Strahlenther Onkol; 2015 Jan; 191(1):59-66. PubMed ID: 25156511
[TBL] [Abstract][Full Text] [Related]
26. Pooled sample-based GWAS: a cost-effective alternative for identifying colorectal and prostate cancer risk variants in the Polish population.
Gaj P; Maryan N; Hennig EE; Ledwon JK; Paziewska A; Majewska A; Karczmarski J; Nesteruk M; Wolski J; Antoniewicz AA; Przytulski K; Rutkowski A; Teumer A; Homuth G; Starzyńska T; Regula J; Ostrowski J
PLoS One; 2012; 7(4):e35307. PubMed ID: 22532847
[TBL] [Abstract][Full Text] [Related]
27. Common genetic variants associated with disease from genome-wide association studies are mutually exclusive in prostate cancer and rheumatoid arthritis.
Orozco G; Goh CL; Al Olama AA; Benlloch-Garcia S; Govindasami K; Guy M; Muir KR; Giles GG; Severi G; Neal DE; Hamdy FC; Donovan JL; Kote-Jarai Z; Easton DF; Eyre S; Eeles RA
BJU Int; 2013 Jun; 111(7):1148-55. PubMed ID: 22985493
[TBL] [Abstract][Full Text] [Related]
28. A replicated association between polymorphisms near TNFα and risk for adverse reactions to radiotherapy.
Talbot CJ; Tanteles GA; Barnett GC; Burnet NG; Chang-Claude J; Coles CE; Davidson S; Dunning AM; Mills J; Murray RJ; Popanda O; Seibold P; West CM; Yarnold JR; Symonds RP
Br J Cancer; 2012 Aug; 107(4):748-53. PubMed ID: 22767148
[TBL] [Abstract][Full Text] [Related]
29. The influence of genetic variation on late toxicities in childhood cancer survivors: A review.
Clemens E; van der Kooi ALF; Broer L; van Dulmen-den Broeder E; Visscher H; Kremer L; Tissing W; Loonen J; Ronckers CM; Pluijm SMF; Neggers SJCMM; Zolk O; Langer T; Zehnhoff-Dinnesen AA; Wilson CL; Hudson MM; Carleton B; Laven JSE; Uitterlinden AG; van den Heuvel-Eibrink MM
Crit Rev Oncol Hematol; 2018 Jun; 126():154-167. PubMed ID: 29759558
[TBL] [Abstract][Full Text] [Related]
30. Clinical factors predicting late severe urinary toxicity after postoperative radiotherapy for prostate carcinoma: a single-institute analysis of 742 patients.
Cozzarini C; Fiorino C; Da Pozzo LF; Alongi F; Berardi G; Bolognesi A; Briganti A; Broggi S; Deli A; Guazzoni G; Perna L; Pasetti M; Salvadori G; Montorsi F; Rigatti P; Di Muzio N
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):191-9. PubMed ID: 21109361
[TBL] [Abstract][Full Text] [Related]
31. A genome-wide pleiotropy scan for prostate cancer risk.
Panagiotou OA; Travis RC; Campa D; Berndt SI; Lindstrom S; Kraft P; Schumacher FR; Siddiq A; Papatheodorou SI; Stanford JL; Albanes D; Virtamo J; Weinstein SJ; Diver WR; Gapstur SM; Stevens VL; Boeing H; Bueno-de-Mesquita HB; Barricarte Gurrea A; Kaaks R; Khaw KT; Krogh V; Overvad K; Riboli E; Trichopoulos D; Giovannucci E; Stampfer M; Haiman C; Henderson B; Le Marchand L; Gaziano JM; Hunter DJ; Koutros S; Yeager M; Hoover RN; ; Chanock SJ; Wacholder S; Key TJ; Tsilidis KK
Eur Urol; 2015 Apr; 67(4):649-57. PubMed ID: 25277271
[TBL] [Abstract][Full Text] [Related]
32. Genetic associations of breast and prostate cancer are enriched for regulatory elements identified in disease-related tissues.
Chen H; Kichaev G; Bien SA; MacDonald JW; Wang L; Bammler TK; Auer P; Pasaniuc B; Lindström S
Hum Genet; 2019 Oct; 138(10):1091-1104. PubMed ID: 31230194
[TBL] [Abstract][Full Text] [Related]
33. Variation in telangiectasia predisposing genes is associated with overall radiation toxicity.
Tanteles GA; Murray RJ; Mills J; Barwell J; Chakraborti P; Chan S; Cheung KL; Ennis D; Khurshid N; Lambert K; Machhar R; Meisuria M; Osman A; Peat I; Sahota H; Woodings P; Talbot CJ; Symonds RP
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):1031-6. PubMed ID: 22677372
[TBL] [Abstract][Full Text] [Related]
34. Impact of VEGF gene polymorphisms and haplotypes on radiation-induced late toxicity in prostate cancer patients.
Langsenlehner T; Renner W; Gerger A; Hofmann G; Thurner EM; Kapp KS; Langsenlehner U
Strahlenther Onkol; 2011 Dec; 187(12):784-91. PubMed ID: 22105769
[TBL] [Abstract][Full Text] [Related]
35. Genome-Wide Association Study of Susceptibility Loci for Radiation-Induced Brain Injury.
Wang TM; Shen GP; Chen MY; Zhang JB; Sun Y; He J; Xue WQ; Li XZ; Huang SY; Zheng XH; Zhang SD; Hu YZ; Qin HD; Bei JX; Ma J; Mu J; Yao Shugart Y; Jia WH
J Natl Cancer Inst; 2019 Jun; 111(6):620-628. PubMed ID: 30299488
[TBL] [Abstract][Full Text] [Related]
36. A systematic review of replication studies of prostate cancer susceptibility genetic variants in high-risk men originally identified from genome-wide association studies.
Ishak MB; Giri VN
Cancer Epidemiol Biomarkers Prev; 2011 Aug; 20(8):1599-610. PubMed ID: 21715604
[TBL] [Abstract][Full Text] [Related]
37. Re-ranking sequencing variants in the post-GWAS era for accurate causal variant identification.
Faye LL; Machiela MJ; Kraft P; Bull SB; Sun L
PLoS Genet; 2013; 9(8):e1003609. PubMed ID: 23950724
[TBL] [Abstract][Full Text] [Related]
38. Higher-than-expected severe (Grade 3-4) late urinary toxicity after postprostatectomy hypofractionated radiotherapy: a single-institution analysis of 1176 patients.
Cozzarini C; Fiorino C; Deantoni C; Briganti A; Fodor A; La Macchia M; Noris Chiorda B; Rancoita PM; Suardi N; Zerbetto F; Calandrino R; Montorsi F; Di Muzio N
Eur Urol; 2014 Dec; 66(6):1024-30. PubMed ID: 24985964
[TBL] [Abstract][Full Text] [Related]
39. Impact of changing rectal dose volume parameters over time on late rectal and urinary toxicity after high-dose intensity-modulated radiotherapy for prostate cancer: A 10-years single centre experience.
Fonteyne V; Sadeghi S; Ost P; Vanpachtenbeke F; Vuye P; Lumen N; De Meerleer G
Acta Oncol; 2015 Jun; 54(6):854-61. PubMed ID: 25387271
[TBL] [Abstract][Full Text] [Related]
40. Replication and meta-analysis of previous genome-wide association studies confirm vezatin as the locus with the strongest evidence for association with endometriosis.
Pagliardini L; Gentilini D; Sanchez AM; Candiani M; Viganò P; Di Blasio AM
Hum Reprod; 2015 Apr; 30(4):987-93. PubMed ID: 25678572
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
